IGF-1LR3 1mg ULTIMA is presented as a product containing IGF-1 LR3, also known as Long R3 IGF-1 or Long-(Arg3)-Insulin-Like Growth Factor-I. For accurate product research, customers should distinguish the scientific identity of IGF-1 LR3 from claims about a specific commercial formulation. The U.S. Food and Drug Administration Substance Registration System identifies Long-(Arg3)-Insulin-Like Growth Factor-I and lists IGF-1 LR3, Insulin-Like Growth Factor Long Chain R3, and Long R3 Insulin-Like Growth Factor-I as synonyms. FDA also states that a UNII record does not itself indicate regulatory review or approval.

IGF-1LR3 1mg ULTIMA Product Information

IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 that has appeared in scientific and laboratory research. Researchers have examined structural modifications because they can change interactions with IGF-binding proteins and related biological pathways. Consequently, Long R3 IGF-1 is generally discussed in research contexts rather than as a conventional consumer medicine. This distinction matters because a research analogue should not automatically be described as equivalent to an approved IGF-1 product.

The stated specification for this listing is 1 mg. However, the exact ULTIMA formulation, manufacturing controls, sterility, identity, and analytical results should be verified from the original packaging and batch documentation. A commercial product name alone cannot establish those details. Therefore, customers researching IGF-1LR3 1mg ULTIMA should review the label, lot information, certificate of analysis, and supplier documentation.

Key Features and Specifications

The primary identifying feature is the stated 1 mg amount associated with the product listing. In addition, related terminology includes Long R3 IGF-1 and Long-(Arg3)-IGF-I. These terms can help customers compare scientific references with product documentation. Nevertheless, they should not be treated as proof that a particular commercial vial contains a verified concentration or meets a specific manufacturing standard.

The regulatory context also deserves attention. FDA substance registration provides a standardized scientific identity, yet the agency explicitly notes that UNII availability does not imply approval. Therefore, a database entry should not be presented as evidence that a commercial ULTIMA product has been approved for human use. Likewise, IGF-1 LR3 should remain distinct from approved medicines containing specific regulated IGF-1 formulations.

Sports compliance is another relevant consideration. The World Anti-Doping Agency lists insulin-like growth factor 1 and its analogues among prohibited growth factors. Consequently, athletes and support personnel subject to anti-doping rules should consult the current rules of their governing organization before using any product associated with IGF-1 or its analogues.

For customers researching this listing, the most useful approach is to focus on verifiable product details rather than unsupported outcome claims. Furthermore, clear product documentation can help distinguish the stated formulation from general information about IGF-1 LR3.

Research Context and Product Evaluation

IGF-1 LR3 has a documented scientific identity, but the FDA record does not establish approval of the specific ULTIMA product. Therefore, customers should evaluate the packaging, lot information, and available analytical documentation separately. In addition, product information should avoid presenting research terminology as proof of effectiveness, safety, or suitability for a particular purpose.

Customers can review product information and ordering options through Iron Elite Nutrition when available. Before placing an order, check the listed specification against the product label and available documentation. Furthermore, check applicable regulations in your location and any rules that apply to sports participation.

Overall, IGF-1LR3 1mg ULTIMA can be described accurately by emphasizing its stated 1 mg specification, scientific identity, research context, and documentation requirements. If you are researching this product, review the available information on Iron Elite Nutrition, confirm the stated specifications, and use reputable scientific and regulatory sources for additional context. Customers should also distinguish product specifications from general scientific information when carefully comparing listings from different sources or suppliers. This approach supports an informative product page without making unsupported medical, performance, or safety claims.